Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 7.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.09 | 52 Week High | $9.58 | |||
| Open | $7.09 | 52 Week Low | $2.34 | |||
| Day High | $7.09 | P/E | N/A | |||
| Day Low | $7.09 | EPS | $-0.34 | |||
| Volume | 117 | |||||
